Search Results - Kevin Haynes
- Showing 1 - 7 results of 7
-
1
-
2
Prescribing cascades in persons with Alzheimer’s disease: engaging patients, caregivers, and providers in a qualitative evaluation of print educational materials by Sarah Bloomstone, Kathryn Anzuoni, Noelle Cocoros, Jerry H. Gurwitz, Kevin Haynes, Vinit P. Nair, Richard Platt, Paula A. Rochon, Sonal Singh, Kathleen M. Mazor
Published in Therapeutic Advances in Drug Safety (2020-10-01)Get full text
Article -
3
Harnessing health plan enrollee data to boost membership in patient-powered research networks by Xiaoxue Chen, Abiy Agiro, W. Benjamin Nowell, Sara Loud, Robert McBurney, Kalen Young, Rebecca Sutphen, Elizabeth Bourquardez Clark, Cristina M. Burroughs, Jeffrey R. Curtis, Antoine G. Sreih, Peter A. Merkel, Kevin Haynes
Published in BMC Health Services Research (2020-05-01)Get full text
Article -
4
Gaps in Evidence‐Based Therapy Use in Insured Patients in the United States With Type 2 Diabetes Mellitus and Atherosclerotic Cardiovascular Disease by Adam J. Nelson, Maddalena Ardissino, Kevin Haynes, Sonali Shambhu, Zubin J. Eapen, Darren K. McGuire, Anthony Carnicelli, Renato D. Lopes, Jennifer B. Green, Emily C. O’Brien, Neha J. Pagidipati, Christopher B. Granger
Published in Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease (2021-01-01)Get full text
Article -
5
Determinants of saxagliptin use among patients with type 2 diabetes mellitus treated with oral anti-diabetic drugs by M Elle Saine, Dean M Carbonari, Craig W Newcomb, Melissa S Nezamzadeh, Kevin Haynes, Jason A Roy, Serena Cardillo, Sean Hennessy, Crystal N Holick, Daina B Esposito, Arlene M Gallagher, Harshvinder Bhullar, Brian L Strom, Vincent Lo Re
Published in BMC Pharmacology and Toxicology (2015-04-01)Get full text
Article -
6
Postauthorization safety study of the DPP-4 inhibitor saxagliptin: a large-scale multinational family of cohort studies of five outcomes by Qing Liu, Sean Hennessy, Qufei Wu, K Rajender Reddy, Arlene M Gallagher, Kevin Haynes, David J Margolis, Brian L Strom, Vincent Lo Re, M Elle Saine, Craig W Newcomb, Jason A Roy, Serena Cardillo, Stephen E Kimmel, Peter P Reese, Andrea J Apter, Harshvinder Bhullar, Daina B Esposito, Dean M Carbonari
Published in BMJ Open Diabetes Research & Care (2017-07-01)Get full text
Article -
7
Contextualising adverse events of special interest to characterise the baseline incidence rates in 24 million patients with COVID-19 across 26 databases: a multinational retrospect... by Erica A. Voss, Azza Shoaibi, Lana Yin Hui Lai, Clair Blacketer, Thamir Alshammari, Rupa Makadia, Kevin Haynes, Anthony G. Sena, Gowtham Rao, Sebastiaan van Sandijk, Clement Fraboulet, Laurent Boyer, Tanguy Le Carrour, Scott Horban, Daniel R. Morales, Jordi Martínez Roldán, Juan Manuel Ramírez-Anguita, Miguel A. Mayer, Marcel de Wilde, Luis H. John, Talita Duarte-Salles, Elena Roel, Andrea Pistillo, Raivo Kolde, Filip Maljković, Spiros Denaxas, Vaclav Papez, Michael G. Kahn, Karthik Natarajan, Christian Reich, Alex Secora, Evan P. Minty, Nigam H. Shah, Jose D. Posada, Maria Teresa Garcia Morales, Diego Bosca, Honorio Cadenas Juanino, Antonio Diaz Holgado, Miguel Pedrera Jiménez, Pablo Serrano Balazote, Noelia García Barrio, Selçuk Şen, Ali Yağız Üresin, Baris Erdogan, Luc Belmans, Geert Byttebier, Manu L.N.G. Malbrain, Daniel J. Dedman, Zara Cuccu, Rohit Vashisht, Atul J. Butte, Ayan Patel, Lisa Dahm, Cora Han, Fan Bu, Faaizah Arshad, Anna Ostropolets, Fredrik Nyberg, George Hripcsak, Marc A. Suchard, Dani Prieto-Alhambra, Peter R. Rijnbeek, Martijn J. Schuemie, Patrick B. Ryan
Published in EClinicalMedicine (2023-04-01)Get full text
Article
